These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28793321)

  • 1. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
    Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
    PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
    Allen MR; Burr DB
    J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene enhances vertebral mechanical properties independent of bone density.
    Allen MR; Iwata K; Sato M; Burr DB
    Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
    Allen MR; Gineyts E; Leeming DJ; Burr DB; Delmas PD
    Osteoporos Int; 2008 Mar; 19(3):329-37. PubMed ID: 18094911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the combination treatment of raloxifene and alendronate on the biomechanical properties of vertebral bone.
    Diab T; Wang J; Reinwald S; Guldberg RE; Burr DB
    J Bone Miner Res; 2011 Feb; 26(2):270-6. PubMed ID: 20687153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.
    Aref M; Gallant MA; Organ JM; Wallace JM; Newman CL; Burr DB; Brown DM; Allen MR
    Bone; 2013 Oct; 56(2):449-53. PubMed ID: 23871851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.
    Kimura S; Saito M; Kida Y; Seki A; Isaka Y; Marumo K
    Osteoporos Int; 2017 Mar; 28(3):1109-1119. PubMed ID: 27796444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs.
    Allen MR; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Newman CL; Burr DB; Hutchins GD
    J Bone Miner Res; 2015 Aug; 30(8):1441-4. PubMed ID: 25644867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
    Huuskonen J; Arnala I; Olkkonen H; Alhava E
    Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
    Ettinger B; San Martin J; Crans G; Pavo I
    J Bone Miner Res; 2004 May; 19(5):745-51. PubMed ID: 15068497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
    Meixner CN; Aref MW; Gupta A; McNerny EMB; Brown D; Wallace JM; Allen MR
    Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra.
    Diab T; Allen MR; Burr DB
    Osteoporos Int; 2009 Apr; 20(4):647-52. PubMed ID: 18716822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
    Sakai S; Endo K; Takeda S; Mihara M; Shiraishi A
    Bone; 2012 May; 50(5):1054-63. PubMed ID: 22366400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.
    Allen MR; Burr DB
    Osteoporos Int; 2008 Jan; 19(1):95-9. PubMed ID: 17710353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass.
    Amugongo SK; Yao W; Jia J; Lay YA; Dai W; Jiang L; Walsh D; Li CS; Dave NK; Olivera D; Panganiban B; Ritchie RO; Lane NE
    Osteoporos Int; 2014 Jun; 25(6):1735-50. PubMed ID: 24722767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS Study.
    Muschitz C; Kocijan R; Fahrleitner-Pammer A; Pavo I; Haschka J; Schima W; Kapiotis S; Resch H
    J Bone Miner Res; 2014 Aug; 29(8):1777-85. PubMed ID: 24619763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density.
    Muschitz C; Kocijan R; Fahrleitner-Pammer A; Lung S; Resch H
    J Bone Miner Res; 2013 Jan; 28(1):196-205. PubMed ID: 22836585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
    Berman AG; Wallace JM; Bart ZR; Allen MR
    Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
    Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
    Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.